We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MIGDAL HA'EMEQ, Israel, July 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active...
EZchip Shareholders Approve Merger Proposal with Mellanox PR Newswire YOKNEAM, Israel, January 19, 2016 YOKNEAM, Israel, January 19, 2016 /PRNewswire/ -- EZchip Semiconductor Ltd. ("EZchip" or...
Transaction Expected To Close in the Second Half of February 2016 Mellanox® Technologies, Ltd. (NASDAQ: MLNX) today announced that its proposed merger with EZchip...
Raging Capital Announces its Support for EZchip/Mellanox Transaction PR Newswire ROCKY HILL, New Jersey, Jan. 7, 2016 ROCKY HILL, New Jersey, Jan. 7, 2016 /PRNewswire/ -- Raging Capital...
Raging Capital Announces its Support for EZchip/Mellanox Transaction PR Newswire ROCKY HILL, N.J., Jan. 6, 2016 ROCKY HILL, N.J., Jan. 6, 2016 /PRNewswire/ -- Raging Capital Management, LLC...
EZchip Files Updated Proxy Materials and Mails Letter to Shareholders EZchip Board Unanimously Recommends Shareholders Vote FOR the Proposed Transaction with Mellanox Technologies, Ltd. PR...
EZchip Announces Expiration of "Go-Shop" Period PR Newswire YOKNEAM, Israel, December 16, 2015 YOKNEAM, Israel, December 16, 2015 /PRNewswire/ -- After Extensive Outreach No New Offers...
Raging Capital Comments on EZchip PR Newswire ROCKY HILL, New Jersey, Dec. 15, 2015 Raises Concerns Over EZchip's Commitment to a Successful Go Shop Process to Maximize Value for...
Raging Capital Comments on EZchip Raises Concerns Over EZchip's Commitment to a Successful Go Shop Process to Maximize Value for Shareholders Continues to Demand Greater Transparency So...
Raging Capital Comments on Shareholder Opposition to Proposed EZchip Merger PR Newswire ROCKY HILL, New Jersey, Nov. 18, 2015 Establishment of a "Go Shop" Period is a Victory for EZchip...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions